671 related articles for article (PubMed ID: 29625858)
1. M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis.
Shrivastava R; Asif M; Singh V; Dubey P; Ahmad Malik S; Lone MU; Tewari BN; Baghel KS; Pal S; Nagar GK; Chattopadhyay N; Bhadauria S
Cytokine; 2019 Jun; 118():130-143. PubMed ID: 29625858
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M upregulates HIF-1α in breast tumor associated macrophages independent of intracellular oxygen concentration.
Shrivastava R; Singh V; Asif M; Negi MPS; Bhadauria S
Life Sci; 2018 Feb; 194():59-66. PubMed ID: 29246543
[TBL] [Abstract][Full Text] [Related]
3. Macrophages are recruited to hypoxic tumor areas and acquire a pro-angiogenic M2-polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin.
Tripathi C; Tewari BN; Kanchan RK; Baghel KS; Nautiyal N; Shrivastava R; Kaur H; Bhatt ML; Bhadauria S
Oncotarget; 2014 Jul; 5(14):5350-68. PubMed ID: 25051364
[TBL] [Abstract][Full Text] [Related]
4. Chamaejasmenin B, an Inhibitor for Metastatic Outgrowth, Reversed M2-Dominant Macrophage Polarization in Breast Tumor Microenvironment.
Li Q; Sun L; Liu L; Ran Q; Du X; Yang Q; Wang Y; Li Y; Chen Y; Weng X; Cai W; Zhu X
Front Immunol; 2021; 12():774230. PubMed ID: 35027915
[TBL] [Abstract][Full Text] [Related]
5. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
6. Separate roles of IL-6 and oncostatin M in mouse macrophage polarization in vitro and in vivo.
Dubey A; Izakelian L; Ayaub EA; Ho L; Stephenson K; Wong S; Kwofie K; Austin RC; Botelho F; Ask K; Richards CD
Immunol Cell Biol; 2018 Mar; 96(3):257-272. PubMed ID: 29363180
[TBL] [Abstract][Full Text] [Related]
7. ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis.
Yang M; Liu J; Piao C; Shao J; Du J
Cell Death Dis; 2015 Jun; 6(6):e1780. PubMed ID: 26068788
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
[TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin B modulates M2 macrophage differentiation and attenuates osteosarcoma progression via PI3K/AKT pathway.
Wu H; Ma T; He M; Xie W; Wang X; Lu L; Wang H; Cui Y
Phytother Res; 2024 May; 38(5):2215-2233. PubMed ID: 38411031
[TBL] [Abstract][Full Text] [Related]
10. Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1/2 signaling.
Cheng Y; Zhong X; Nie X; Gu H; Wu X; Li R; Wu Y; Lv K; Leung GP; Fu C; Lee SM; Zhang J; Li J
Phytomedicine; 2023 Jun; 114():154757. PubMed ID: 37011418
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
[TBL] [Abstract][Full Text] [Related]
12. Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling.
Bossler F; Kuhn BJ; Günther T; Kraemer SJ; Khalkar P; Adrian S; Lohrey C; Holzer A; Shimobayashi M; Dürst M; Mayer A; Rösl F; Grundhoff A; Krijgsveld J; Hoppe-Seyler K; Hoppe-Seyler F
mBio; 2019 Feb; 10(1):. PubMed ID: 30755508
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 inhibition attenuates hypoxic cancer cells induced m2-polarization of macrophages.
Dubey P; Shrivastava R; Tripathi C; Jain NK; Tewari BN; Lone MU; Baghel KS; Kumar V; Misra S; Bhadauria S; Bhatt ML
Cell Mol Biol (Noisy-le-grand); 2014 Sep; 60(3):10-5. PubMed ID: 25210855
[TBL] [Abstract][Full Text] [Related]
14. Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs.
Jia X; Yu F; Wang J; Iwanowycz S; Saaoud F; Wang Y; Hu J; Wang Q; Fan D
Breast Cancer Res Treat; 2014 Nov; 148(2):291-302. PubMed ID: 25311112
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation.
Huang SC; Smith AM; Everts B; Colonna M; Pearce EL; Schilling JD; Pearce EJ
Immunity; 2016 Oct; 45(4):817-830. PubMed ID: 27760338
[TBL] [Abstract][Full Text] [Related]
16. Anemoside A3 activates TLR4-dependent M1-phenotype macrophage polarization to represses breast tumor growth and angiogenesis.
Yin L; Fan Z; Liu P; Chen L; Guan Z; Liu Y; Luo Y
Toxicol Appl Pharmacol; 2021 Dec; 432():115755. PubMed ID: 34673087
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis.
Wang X; Gao S; Song L; Liu M; Sun Z; Liu J
Mol Immunol; 2021 Feb; 130():113-121. PubMed ID: 33308900
[TBL] [Abstract][Full Text] [Related]
18. TIS21
Sundaramoorthy S; Devanand P; Ryu MS; Song KY; Noh DY; Lim IK
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1445-1462. PubMed ID: 29808317
[TBL] [Abstract][Full Text] [Related]
19. POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages.
Seoane S; Martinez-Ordoñez A; Eiro N; Cabezas-Sainz P; Garcia-Caballero L; Gonzalez LO; Macia M; Sanchez L; Vizoso F; Perez-Fernandez R
J Pathol; 2019 Nov; 249(3):381-394. PubMed ID: 31292963
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer.
Mu X; Shi W; Xu Y; Xu C; Zhao T; Geng B; Yang J; Pan J; Hu S; Zhang C; Zhang J; Wang C; Shen J; Che Y; Liu Z; Lv Y; Wen H; You Q
Cell Cycle; 2018; 17(4):428-438. PubMed ID: 29468929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
